Empathic Communication Skills (ECS) Training
Memorial Sloan Kettering Cancer Center · with American Cancer Society, Inc., Go2 Foundation for Lung Cancer · NCT05456841
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1232
- US sites recruiting
- 8
- Study start
- April 28, 2023
- Record last updated
- October 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Being studied: Empathic Communication Skills (ECS) training; Standard of Care participant interaction
Conditions: Lung Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Site Eligibility
- Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
- Reports a clinic volume of at least 20 new lung cancer patients per month as per self report
OCP Participant Eligibility
- OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
- OCP conducts consultations with lung cancer patients, as per self-report;
- OCP sees at least 1 lung cancer patient per week, as per self-report;
Patient Eligibility
- Patient under the care of a participating OCP as per self report;
- English and/or Spanish speaking;
- In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
- If English, treat as fluent in English, no additional language questions
- If Spanish, treat as fluent in Spanish, no additional language questions
- If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
- How well do you speak English? Not at all/ Not well/Well/Very well
- How well do you speak Spanish? Not at all/Not well/Well/Very well
- Is at least 18 years of age as per self report;
- Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
- Is a former or current smoking as per self report;
- Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
Exclusion Criteria
Patient Exclusion
- Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.
Site and OCP Exclusion
- None
Recruiting US locations
BAPTIST ALLIANCE - MCI (Data Collection Only)
Miami, FL 33143
Site contact: Ian Bostock, MD · 786-596-2000
Advocate Health Care Network
Libertyville, IL 60048
Site contact: Michael Breen, MD · 847-367-6781
Hackensack Meridian Health (Data collection only)
Hackensack, NJ 07601
Site contact: David Greenberg, MD · 551-996-8704
Roswell Park Cancer Institute (Data Collection Only)
Buffalo, NY 14263-0001
Site contact: Elisabeth Dexter, MD · 716-845-2300
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, NY 10065
Site contact: Smita Banerjee, PhD · 646-888-0011
University of Pennsylvania (Data Collection Only)
Philadelphia, PA 19104-4283
Site contact: Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP · (215) 615-5858
Fox Chase Cancer Center (Data Collection Only)
Philadelphia, PA 19111
Site contact: Linda Fleisher, PhD, MPH · 215-728-4066
Chesapeake Regional Healthcare (Data Collection Only)
Chesapeake, VA 23320
Site contact: Stephen Noble, MD · 757-842-4499
Study contacts (from the official record)
- Smita Banerjee, PhD · 646-888-0011 · banerjes@mskcc.org
- Jamie Ostroff, PhD · 646-888-0041 · ostroffj@mskcc.org
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65